serine has been researched along with Granulocytic Leukemia, Chronic in 7 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite the use of targeted therapy, chronic myelogenous leukemia (CML) currently remains incurable with drug therapy, with patients requiring life-long treatment." | 1.40 | Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells. ( Jaymacker, J; Mowla, S; Njikan, S; Novitzky, N; Shankland, I; Shires, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, J | 1 |
| Cao, D | 1 |
| Zhang, Y | 1 |
| Ou, R | 1 |
| Yin, Z | 1 |
| Liu, Y | 1 |
| Huang, G | 1 |
| Gu, C | 1 |
| Chen, S | 1 |
| Fei, J | 1 |
| Shires, K | 1 |
| Shankland, I | 1 |
| Mowla, S | 1 |
| Njikan, S | 1 |
| Jaymacker, J | 1 |
| Novitzky, N | 1 |
| Müller-Tidow, C | 1 |
| Kiehl, M | 1 |
| Sindermann, JR | 1 |
| Probst, M | 1 |
| Banger, N | 1 |
| Zühlsdorf, M | 1 |
| Chou, TC | 1 |
| Berdel, WE | 1 |
| Serve, H | 1 |
| Koch, OM | 1 |
| Sawafuji, K | 1 |
| Miyakawa, Y | 1 |
| Weisberg, E | 1 |
| Griffin, JD | 1 |
| Ikeda, Y | 1 |
| Kizaki, M | 1 |
| Goldberg, Z | 1 |
| Levav, Y | 1 |
| Krichevsky, S | 1 |
| Fibach, E | 1 |
| Haupt, Y | 1 |
| Kaur, S | 1 |
| Parmar, S | 1 |
| Smith, J | 1 |
| Katsoulidis, E | 1 |
| Li, Y | 1 |
| Sassano, A | 1 |
| Majchrzak, B | 1 |
| Uddin, S | 1 |
| Tallman, MS | 1 |
| Fish, EN | 1 |
| Platanias, LC | 1 |
| Lin, F | 1 |
| Monaco, G | 1 |
| Sun, T | 1 |
| Liu, J | 1 |
| Lin, H | 1 |
| Stephens, C | 1 |
| Belmont, J | 1 |
| Arlinghaus, RB | 1 |
7 other studies available for serine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis.
Topics: Animals; Apoptosis; Carcinogenesis; Cell Proliferation; Colony-Forming Units Assay; Drug Resistance, | 2020 |
Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells.
Topics: Amino Acid Sequence; Animals; Cell Surface Display Techniques; Clone Cells; Fibroblasts; Fusion Prot | 2014 |
Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Fragmentation; Do | 2003 |
Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
Topics: Aminopeptidases; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Cas | 2003 |
Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage.
Topics: Antineoplastic Agents; Benzamides; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kina | 2004 |
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells.
Topics: Cell Line, Tumor; DNA-Binding Proteins; Enzyme Activation; Humans; Immunoprecipitation; Interferon-a | 2005 |
BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model.
Topics: Animals; Fusion Proteins, bcr-abl; Gene Expression Regulation; Humans; K562 Cells; Leukemia, Myeloge | 2001 |